Kosé is developing personalized skin care using consumers’ own iPS cells via Global Cosmetic Industry

Kosé is partnering with I Peace, Inc. and Reju, Inc. to develop personalized beauty products comprising iPSF (an induced pluripotent stem [iPS] cell extract) derived from customers’ own blood-drawn cells.

This process will reportedly optimize dosages and textures for each consumer; finished products will reportedly be “provided through medical institutions under medical supervision,” per Kosé.

By the end of 2024, iPSF-based formulations will commence demonstrating testing in Japan.

Read more

Recent Posts

Can cosmetic products be harmful? The path of nanoparticles through mucous membranes and skin membranes by Microscopy Services

Nanoparticles have a bad reputation among the general public. There is great uncertainty as to…

Imasens haircare innovation area

In an ever-changing and increasingly competitive hair care market, sensory profiling is a real asset…

The Moisturizing claim: how to substantiate it? Approaches, requirements and validation methods by Taobé Consulting

Taobé Consulting specializes in helping cosmetic brands navigate complex European and UK regulatory frameworks, providing…